Structural and functional properties of membrane and secreted IgD

Molecular Immunology

Volumn 37, Issue 15, 2000, Pages 871-887

  Preud'homme, Jean Louis ^a   Petit, Isabelle ^a   Barra, Anne ^a   Morel, Jean Claude Lecron, Franck ^a   Lelièvre, Eric ^a  

^a POITIERS UNIVERSITY HOSPITAL   (France)

Author keywords

B cell receptor; IgD

Indexed keywords

B LYMPHOCYTE RECEPTOR; CD40 ANTIGEN; GAMMA INTERFERON; HYPERIMMUNE GLOBULIN; IMMUNOGLOBULIN D; IMMUNOGLOBULIN M; IMMUNOGLOBULIN RECEPTOR; INTERLEUKIN 2; INTERLEUKIN 4; MESSENGER RNA;

ANTIBODY RESPONSE; B LYMPHOCYTE; CELL MEMBRANE; EXON; GENETIC TRANSCRIPTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; IMMUNE DEFICIENCY; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN GENE; IMMUNOGLOBULIN PRODUCTION; IMMUNOGLOBULIN STRUCTURE; IMMUNOSTIMULATION; LYMPHOPROLIFERATIVE DISEASE; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; ONTOGENY; PLASMA CELL; PLASMA HALF LIFE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; T LYMPHOCYTE;

ANIMALS; CELL MEMBRANE; HUMANS; IMMUNOGLOBULIN D; RECEPTORS, CELL SURFACE; RECEPTORS, FC; RECEPTORS, IMMUNOLOGIC;

EID: 0035078170     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-5890(01)00006-2     Document Type: Article

References (241)

1. IgD-binding factors from mouse T lymphocytes
2. The specificity of association of the IgD molecule with the accessory proteins BAP31/BAP29 lies in the IgD transmembrane sequence
3. B-cell suppression in adult mice injected with anti-delta followed by anti-mu mAb
4. Release of IgD-binding factor by T cells under the influence of interleukin 2, interleukin 4, or cross-linked IgD
5. Regulation of IgD-receptor expression on murine T cells. II. Upregulation of IgD receptors is obtained after activation of various intracellular second-messenger systems; tyrosine kinase activity is required for the effect of IgD
6. Specificity of the murine IgD receptor on T cells is for N-linked glycans on IgD molecules
7. The immunoaugmenting properties of murine IgD reside in its C delta 1 and C delta 3 regions: Potentiel role for IgD-associated glycans
8. Non-X-linked hyper-IgM syndrome with systemic lupus erythematosus
9. The normal counterpart of IgD myeloma cells in germinal center displays extensively mutated IgVH gene, Cmu-Cdelta switch, and lambda light chain expression
10. MAZ-dependent termination between closely spaced human complement genes
11. Characterization of jacalin, the human IgA and IgD binding lectin from jackfruit
12. Jacalin: A new laboratory tool in immunochemistry and cellular immunology
13. Efficacy of the placental barrier for immunoglobulins: Correlations between maternal, paternal and fetal immunoglobulin levels
14. Hyperimmunoglobulinemia D following cancer chemotherapy
15. Sequential changes of the five immunoglobulin classes and other responses in infectious mononucleosis
16. Changes in serum IgD in cigarette smokers
17. Elevated IgD antibodies to wheat in celiac disease
18. Distribution of immunoglobulin producing cells is different in normal human appendix and colon mucosa
19. Immunoglobulin D multiple myeloma: Presenting features, response to therapy, and survival in a series of 53 cases
20. Proliferative response of human CD4+ T lymphocytes stimulated by the lectin jacalin
21. Overview of the mucosal immune system
22. Significance of different J chain profiles in human tissues: Generation of IgA and IgM with binding site for secretory component is related to the J chain expressing capacity of the total local immunocyte population, including IgG and IgD producing cells, and depends on the clinical state of the tissue
23. Production and secretion of immunoglobulins in the gastrointestinal tract
24. The human secretory immune system shows striking heterogeneity with regard to involvement of J chain-positive IgD immunocytes
25. The clinical condition of IgA-deficient patients is related to the proportion of IgD- and IgM-producing cells in their nasal mucosa
26. IgD expression on B cells is more efficient than IgM but both receptors are functionally equivalent in up-regulation CD80/CD86 co-stimulatory molecules
27. Immunoglobulin M and D antigen receptors are both capable of mediating B lymphocyte activation, deletion, or anergy after interaction with specific antigen
28. Immunoglobulin diversity, B-cell and antibody repertoire development in large farm animals
29. B-cell tolerance. III. Effect of papain-mediated cleavage of cell surface IgD on tolerance susceptibility of murine B cells
30. Alpha-chains of IgM and IgD antigen receptor complexes are differentially N-glycosylated MB-1-related molecules
31. A role for immunoglobulin D: Interference with tolerance induction
32. Detectability and pattern of immunoglobulins in normal amniotic fluid throughout gestation
33. IgD and the fetal immune response
34. The gene for familial Mediterranean fever, MEFV, is expressed in early leucocyte development and is regulated in response to inflammatory mediators
35. Evidence for an IgD homologue on chicken lymphocytes
36. Serum immunoglobulin elevations in the acquired immunodeficiency syndrome (AIDS): Igg, IgA, IgM and IgD
37. A new multivalent B cell activation model - Anti-IgD bound to Fc gamma RI: Properties and comparison with CD40L-mediated activation
38. Physiology of IgD. VII. Induction of receptors for IgD on cloned T cells by IgD and interleukin 2
39. Exposure to crosslinked IgD induces receptors for IgD on T cells in vivo and in vitro
40. Physiology of IgD. VIII. Age-related decline in the capacity to generate T cells with receptors for IgD and partial reversal of the defect with IL2
41. Role of IgD and T delta cells in the regulation of the humoral immune response
42. IgD-receptor positive human T lymphocytes. I. Modulation of receptor expression by oligomeric IgD and lymphokines
43. IgD-receptor positive human T lymphocytes. II. Identification and partial characterization of human IgD-binding factor
44. Physiology of IgD. VI. Transfer of the immunoaugmenting effect of IgD with T delta-containing helper cell populations
45. Polygenic autoimmune traits: Lyn, CD22, and SHP-1 are limiting elements of a biochemical pathway regulating BCR signaling and selection
46. Correlation of serum IgD level with clinical and histologic parameters in Hodgkin disease
47. Increased serum IgD concentrations in patients with Hodgkin's disease
48. Serum immunoglobulin class and IgG subclass levels and the occurrence of homogeneous immunoglobulins during the course of ageing in humans
49. Immunoglobulin levels during follow-up of children with selective IgA deficiency
50. Mutations in the MEFV gene in a large series of patients with a clinical diagnosis of familial Mediterranean fever
51. Mutations in the gene encoding mevalonate kinase cause hyper-IgD and periodic fever syndrome. International hyper-IgD study group
52. Immunoglobulin D enhances the release of tumor necrosis factor-alpha, and interleukin-1 beta as well as interleukin-1 receptor antagonist from human mononuclear cells
53. Hyperimmunoglobulinemia D and periodic fever syndrome. The clinical spectrum in a series of 50 patients. International hyper-IgD study group
54. Unstimulated peripheral blood mononuclear cells from patients with the hyper-IgD syndrome produce cytokines capable of potent induction of C-reactive protein and serum amyloid A in Hep3B cells
55. Cytokine activation during attacks of the hyperimmunoglobulinemia D and periodic fever syndrome
56. Measurement of IgD by a double antibody radioimmunoassay: Demonstration of an apparent trimodal distribution of IgD levels in normal human sera
57. Inheritance of low serum immunoglobulin D
58. Abnormal B lymphocyte development, activation and differentiation in mice that lack or overexpress the CD19 signal transduction molecule
59. Cross-linking of membrane immunoglobulin D, in the absence of T cell help, kills mature B cells in vivo
60. Polyclonal activation of the murine immune system by an antibody to IgD. VII. Demonstration of the role of non-antigen-specific T help in in vivo B cell activation
61. Polyclonal activation of the murine immune system by a goat antibody to mouse IgD. IX. Induction of a polyclonal IgE response
62. Cell membrane IgD: Demonstration of IgD on human lymphocytes by enzyme-catalysed iodination and comparison with cell surface Ig of mouse, guinea pig, and rabbit
63. Demonstration of mouse serum IgD
64. Many bacterial species bind human IgD
65. IgE and IgD antibodies to cow milk and soy protein in duodenal fluid: Effects of pancreozymin and secretin
66. Mevalonate kinase deficiency and Dutch type periodic fever
67. Immunoglobulin D (IgD) in childhood. II. Serum IgD levels in juvenile rheumatoid arthritis
68. Illegitimate recombination generates a class switch from C mu to C delta in an IgD-secreting plasmocytoma
69. Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice
70. Polyclonal activation of the murine immune system by an antibody to IgD. XI. Contribution of membrane IgD cross-linking go the generation of an in vivo polyclonal antibody response
71. Sites of 'spontaneous' degradation of IgD
72. Proteolytic degradation of IgD and its relation to molecular conformation
73. Serum immunoglobulin and complement interrelationships in juvenile rheumatoid arthritis
74. Immunological studies in the hyper-immunoglobulin D syndrome
75. Serum immunoglobulin D in infants and children
76. mIgM: Migd ratios on B cells: Mean mIgD expression exceeds mIgM by 10-fold on most splenic B cells
77. Multiple defects in the immune system of Lyn-deficient mice, culminating in autoimmune disease
78. Clinical and immunological studies in patients with an increased serum IgD level
79. Molecular cloning and phylogenetic analysis of the Atlantic salmon immunoglobulin D gene
80. Mutations in MVK, encoding mevalonate kinase, cause hyperimmunoglobulinaemia D and periodic fever syndrome
81. Selective partial IgM deficiency: Functional assessment of T and B lymphocytes in vitro
82. Analysis of the mechanism, rate, and sites of proteolytic cleavage of human immunoglobulin D by high-pressure liquid chromatographiy
83. IgD multiple myeloma. Review of 133 cases
84. Serum IgD concentrations in normal infants, children, and adults and in patients with elevated IgE
85. IgD in human colostrum
86. Regulation of IgM and IgD expression in human B-lineage cells
87. Levels of IgD in patients with rheumatoid arthritis
88. The B cell antigen receptor of class IgD induces a stronger and more prolonged protein tyrosine phosphorylation than that of class IgM
89. Two new proteins preferentially associated with membrane immunoglobulin D
90. Differential regulation of transcription termination occurring at two different sites on the mu-delta gene complex
91. IgD monoclonal gammopathy of undetermined significance
92. Satterwhite E, Dyer MJ. IgD class switching: Identification of a novel recombination site in neoplastic and normal B cells
93. Quantitative immunohistochemistry of immunoglobulin- and J-chain-producing cells in human parotid and submandibular salivary glands
94. Immunohistochemical evaluation of J-chain expression by intra- and extra-follicular immunoglobulin-producing human tonsillar cells
95. Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM
96. Transient increase of serum IgD levels after allogeneic bone-marrow transplantation
97. Hyperimmunoglobulinemia D in idiopathic retinal vasculitis
98. The human immunoglobulin Cμ-Cδ locus: Regulation of μ and δ RNA expression during B cell development
99. Rapid stimulation of large specific antibody responses with conjugates of antigen and anti-IgD antibody
100. Structure and biological functions of human IgD. IV. Ontogeny of human serum immunoglobulin D (IgD) as related to IgG, IgA and IgM
101. A sensitive ELISA for human IgD measurement in neonate, infant and adult sera and lymphocyte culture supernatants
102. Th2 cytokine dependence of IgD production by normal human B cells
103. Structural studies of human IgD: Isolation by a two-step purification procedure and characterization by chemical and enzymatic fragmentation
104. Primary structure of the Fc region of human immunoglobulin D: Implication for evolutionary origin and biological functions
105. IgD serum levels are influenced by HLA-DR phenotype
106. Membrane IgD-positive B cells of 'low-IgD serum phenotype' individuals fail to secrete IgD and fail to shift to preferential lambda light-chain expression in vitro
107. In vitro studies on human IgD. I. Sources and characteristics of 'externalized' IgD in tonsil lymphocyte cultures
108. In vitro studies on human IgD. II. IgD-secreting cells preferentially elaborate IgD, lambda molecules
109. In vitro studies on human IgD. III. Immunologic features of individuals with high sera IgD and spontaneous IgD biosynthesis
110. Studies on human low serum IgD phenotype and Gm markers
111. Selective concentration of IgD clas-specific antibodies in human milk
112. Serum IgD levels in children under investigation for and with defined immunodeficiency
113. Normal human IgD+ IgM- germinal center B cells can express up to 80 mutations in the variable region of their IgD transcripts
114. Familial Mediterranean fever and hyperimmunoglobulinemia D syndrome: Two diseases with distinct clinical, serologic, and genetic features
115. Structure and biological functions of human IgD. VI. Serum IgD in patients with allergic bronchopulmonary aspergillosis
116. Structure and biological functions of human IgD. VII. IgD antinuclear antibodies in sera of patients with autoimmune disorders
117. IgD can largely substitute for loss of IgM function in B cells
118. Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes
119. Maternal smoking influences cord serum IgE and IgD levels and increases the risk for subsequent infant allergy
120. Transcriptional enhancers and the evolution of the IgH locus
121. The role of DNA rearrangement and alternative RNA processing in the expression of immunoglobulin delta genes
122. Immunoglobulin class and subclass antibodies to HIV proteins in maternal serum: Association with perinatal transmission
123. Lymphocyte surface IgD and IgM in non-human primates
124. Positive and negative signals transduced through surface immunoglobulins in human B cells
125. The effect of institutionalisation on elevated IgD and IgG levels in patients with Down's syndrome
126. Structures of the O-glycosidally linked oligosaccharides of human IgD
127. B-cell activation in HIV infection: Relationship of spontaneous immunoglobulin secretion to various immunological parameters
128. Serum IgD elevation is an early marker of B cell activation during infection with the human immunodeficiency viruses
129. B lymphocyte activation: Entry into cell cycle is accompanied by decreased expression of IgD but not IgM
130. Regulatory elements necessary for termination of transcription within the Ig heavy chain gene locus
131. Expression of IgD may use both DNA rearrangement and RNA splicing mechanisms
132. Interleukin (IL)-4-independent immunoglobulin class switch to immunoglobulin (Ig)E in the mouse
133. In vivo IL-4 responses to anti-IgD antibody are MHC class II dependent and beta-2-microglobulin independent and develop normally in the absence of IL-4 priming of T cells
134. Specific serum immunoglobulin D, detected by antibody capture enzyme-linked immunosorbent assay (ELISA), in cytomegalovirus infection
135. Virus-specific IgD in acute viral infection of mice
136. The in vivo generation of murine IgD-secreting cells is accompanied by deletion of the C mu gene and occasional deletion of the gene for the C delta 1 domain
137. Polyclonal activation of the murine immune system by an antibody to IgD. VIII. Stimulation of IgD secretion
138. Membrane exon sequences of the three Xenopus Ig classes explain the evolutionary origin of mammalian isotypes
139. Surface Ig on B lymphocytes from cattle and sheep
140. Switch from hapten-specific immunoglobulin M to immunoglobulin D secretion in a hybrid mouse cell line
141. Memory B lymphocytes in human tonsil do not express surface IgD
142. Abnormal serum immunoglobulin levels in Down's syndrome patients
143. Immunoglobulin D-deficient mice can mount normal immune responses to thymus-independent and -dependent antigens
144. Serum IgD in subjects with and without chronic obstructive pulmonary disease: A previous finding restudied
145. CD22 regulates thymus-independent responses and the lifespan of B cells
146. Immunoglobulin D in cerebrospinal fluid
147. Non-homologous recombination at sites within the mouse JH-C delta locus accompanies C mu deletion and switch to immunoglobulin D secretion
148. Maternal smoking does not influence cord serum IgE or IgD concentrations
149. The presence of immunoglobulin D in endocrine disorders and diseases of immunoregulation, including the acquired immunodeficiency syndrome
150. Differential structure - Function requirements of the transmembranal domain of the B cell antigen receptor
151. Measles virus-specific immunoglobulin D antibody in cerebrospinal fluid and serum from patients with subacute sclerosing panencephalitis and multiple sclerosis
152. Total serum IgD is increased in atopic subjects
153. IgD and IgM on the membrane of lymphoid cells in macroglobulinemia. Evidence for identity of membrane IgD and IgM antibody activity in a case with anti-IgG receptors
154. Jacalin: A lectin mitogenic for human CD4 T lymphocytes
155. Stimulation of peripheral blood lymphocytes of HIV-infected patients by jacalin, a lectin mitogenic for human CD4+ lymphocytes
156. IgM and IgD concentrations in the serum and secretions of children with selective IgA deficiency
157. Circulating autoantibodies to IgD in rheumatic diseases
158. Loss of surface IgD by human B lymphocytes during polyclonal activation
159. Surface IgD in immunoproliferative disorders
160. Membrane-bound IgD on human lymphoid cells, with special reference to immunodeficiency and immunoproliferative diseases
161. Immunoglobulin D bearing lymphocytes in primary immunodeficiencies
162. Serum IgD behaviour in HIV-1 infected patients
163. Role of differential mRNA stability in the regulated expression of IgM and IgD
164. Initiation and processing of signals from the B cell antigen receptor
165. Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the hyper-IgM syndrome
166. Transcriptional regulation of B-cell differentiation
167. Cell autonomous expression of IgD is not essential for the maturation of conventional B cells
168. Immunoglobulin D (IgD)-deficient mice reveal an auxiliary receptor function for IgD in antigen-mediated recruitment of B cells
169. IgD production and other lymphocyte functions in HIV infection: Immaturity and activation of B cells at different clinical stages
170. Serum IgG and IgD levels in some infectious and non-infectious diseases
171. A new class of human immunoglobulins
172. IgD on the surface of periphal blood lymphocytes of human newborn
173. Immunoglobulin D as lymphocyte receptor
174. A human T-cell receptor recognizes 'O'-linked sugars from the hinge region of human IgA1 and IgD
175. Structure and biologic functions of human IgD. XI. Identification and ontogeny of a rat lymphocyte immunoglobulin having antigenic cross-reactivity with human IgD
176. Serum immunoglobulin levels in normal, premature and postmature newborns and their mothers
177. Kinetics of specific IgA, IgD, IgE, IgG, and IgM antibody responses in rubella
178. CD22 is both a positive and negative regulator of B lymphocyte antigen receptor signal transduction: Altered signaling in CD22-deficient mice
179. Increased serum IgD concentrations in children with Henoch-Schonlein purpura
180. Monomeric and oligomeric complexes of the B cell antigen receptor
181. Periodic fever syndromes
182. IgE and IgD concentrations in patients with recurrent aphtous stomatitis
183. On the influence of age on immunity in Down's syndrome
184. The natural antibody response to E. coli includes antibodies of the IgD class
185. Importance of intrathecal synthesis of IgD in multiple sclerosis. A combined clinical, immunologic, and magnetic resonance imaging study
186. Serum immunoglobulin levels in the course of anaphylactoid purpura in children
187. Presence of receptors for IgD on human T and non-T lymphocytes
188. Immunoglobulin E production in the absance of interleukin-4-secreting CD1-dependent cells
189. The structure and biology of human IgD
190. Biological role of different antibody classes
191. IgD antibodies to DNP are specifically induced in ascitic fluid after intraperitoneal immunization
192. Immunoglobulin D (IgD) of Atlantic cod has a unique structure
193. Serum IgA, IgM, and IgD in allergic (type I) and non-allergic respiratory diseases
194. Concentration of serum immunoglobulins in acute and chronic hepatic diseases. I. Serum levels of IgG, IgA, IgM and IgD in young patients with viral hepatitis
195. Concentration of serum immunoglobulins in acute and chronic hepatic diseases. II. Viral hepatitis; time-dependent changes in immunoglobulin concentration
196. Biologic variation of human immunoglobulin concentration. I. Sex-age specific effects on serum levels of IgG, IgA, IgM and IgD
197. Immunoglobulin systems of human tonsils. II. Patients with chronic tonsilitis or tonsillar hyperplasia: Quantification of Ig-producing cells, tonsillar morphometry and serum Ig concentrations
198. Cytokine gene expression after in vivo primary immunization with goat antibody to mouse IgD antibody
199. The effect of aging on IgD receptor expression by T cells and its functional implications
200. Regulation of IgD-receptor expression on murine T cells. I. Characterization and metabolic requirements of the process leading to their expression
201. IgD-receptor up-regulation on human peripheral blood T cells in response to IgD in vitro or antigen in vivo correlates with the antibody response to influenza vaccination
202. Regulation of IgD-receptor expression on murine T cells. IV. dehydroepiandrosterone enhances antibody production in young and aged mice by induction of IgD-receptors on T cells
203. Oligomeric IgD augments and monomeric IgD inhibits the generation of IgG memory antibody responses in normal, but not in IgD-deficient, mice
204. Physiology of IgD. IX. Effect of IgD on immunoglobulin production in young and old mice
205. Levels of polyadenylation factor CstF-64 control IgM heavy chain mRNA accumulation and other events associated with B cell differentiation
206. The polyadenylation factor CstF-64 regulates alternative processing of IgM heavy chain pre-mRNA during B cell differentiation
207. IgD receptors on murine T-helper cells bind to Fd and Fc regions of immunoglobulin D
208. IgD-recptor positive human T lymphocytes. II Identificaiton and partial characterization of human IgD-binding factor
209. IgD-bearing human lymphocytes
210. Hyperimmunoglobulinaemia D and periodic fever: A new syndrome
211. IgG2b or IgE molecules can be co-expressed with those of the IgM and IgD isotypes on the membrane of normal rat B cells
212. Light chain types of IgD in human bone marrow and serum
213. Serum immunoglobulin levels in childhood Hodgkin's disease. Effect of splenectomy and long-term follow-up
214. The IgD-receptor positive human T lymphocytes II: Total absence of any IgD-receptor expression in a large percentage of healthy aged individuals
215. Analysis of immunoglobulin heavy chain delta transcription termination in the production of delta S or delta M mRNA
216. Analysis of immunoglobulin (Ig) isotype diversity ant IgM/D memory in the response to phenyl-oxazolone
217. Human immunoglobulin D: Genomic sequence of the delta heavy chain
218. Immunoglobulin D switching can occur through homologous recombination in human B cells
219. Glycosyl-phosphatidylinositol linkage as a mechanism for cell-surface expression of immunoglobulin D
220. Molecular components of the B cell antigen receptor complex of class IgD differ partly from those of IgM
221. The B cell antigen receptor of class IgD can be expressed on the cell surface in two different forms
222. The prevalence and possible significance of IgD granulocyte-specific antinuclear antibodies in neutropenic and non-neutropenic cases of rheumatoid arthritis
223. A novel chimeric Ig heavy chain from a teleost fish shares similarities to IgD
224. Receptor revision of immunoglobulin heavy chain variable region genes in normal human B lymphocytes
225. The human immunoglobulin C mu-C delta locus: Complete nucleotide sequence and structural analysis
226. Roles of calnexin and Ig-αβ interactions with membrane Igs in the surface expression of the B cell antigen receptor of the IgM and IgD classes
227. Physiology of IgD. IV. Enhancement of antibody production in mice bearing IgD-secreting plasmocytomas
228. Physiology of IgD. III. Effect of treatment with anti-IgD from birth on the magnitude and isotype distribution of the immune response in the spleen
229. In vitro enhancement of antibody responses by T delta cells expressing IgD receptors
230. Class switch from μ to δ is mediated by homologous recombination between sμ and sμ sequences in human immunoglobulin gene loci
231. Role of NK1.1+ T cells in a TH2 response and in immunoglobulin E production
232. Regulation of IgM and IgD synthesis in B lymphocytes. II. Translational and post-translational events
233. Regulation of immunoglobulin D synthesis in murine neonatal B lymphocytes
234. Regulation of IgM and IgD synthesis in B lymphocytes. I. Changes in biosynthesis of mRNA for mu- and delta-chains
235. Transcriptional regulation of the mu-delta heavy chain locus in normal murine B lymphocytes
236. Transcriptional regulation of mu and delta gene expression in bone marrow pre-B and B lymphocytes
237. Regulation of IgM and IgD heavy chain gene expression: Effect of abrogation of intergenic transcriptional termination
238. Serum immunoglobulins in healthy children and adults. Levels of the five classes, expressed in international units per millilitre
239. The serum IgG subclass levels in healthy infants of 13-62 weeks of age
240. Human IgD and IgA1 compete for d-galactose-related binding sites on the lectin jacalin
241. Measurement of allergen-specific IgD and correlation with allergen-specific IgE